Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2026-01-30

FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Marlex Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for venlafaxine hydrochloride (ANDA201272) from Marlex Pharmaceuticals, Inc., authorizing continued marketing of a gener…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Venlafaxine hydrochloride (Venlafaxine hydrochloride)

Snippet

SUPPL AP for VENLAFAXINE HYDROCHLORIDE (VENLAFAXINE HYDROCHLORIDE)